Analog Devices (ADI) CEO exercises options and sells 10,000 shares

Rhea-AI Filing Summary

Analog Devices Chair & CEO Vincent Roche reported option and share transactions on February 2, 2026. He exercised 10,000 non-qualified stock options at $94.41 per share, receiving 10,000 shares, then sold 10,000 shares of common stock at $306.92 per share under a pre-arranged 10b5-1 plan.

After these trades, Roche directly holds 155,688.462 Analog Devices common shares and 44,637 stock options. An additional 23,515 shares are held indirectly through the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024.

Insider Trade Summary

Net Seller: 10,000 shares ($3,069,200)

Net Sell 4 txns

Insider ROCHE VINCENT

Role Chair & CEO

Sold 10,000 shs ($3.07M)

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Stock Option (right to buy)	10,000	$94.41	$944K
Exercise	Comm Stock - $.16-2/3 value	10,000	$94.41	$944K
Sale	Comm Stock - $.16-2/3 value	10,000	$306.92	$3.07M
holding	Comm Stock-$.16-2/3 value	--	--	--

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 44,637 shares (Direct); Comm Stock - $.16-2/3 value — 165,688.462 shares (Direct); Comm Stock-$.16-2/3 value — 23,515 shares (Indirect, Vincent Roche 2024 Grantor Retained Annuity Trust)

Footnotes (1)

1. These shares were sold pursuant to a 10b5-1 plan adopted by the Reporting Person on May 23, 2025. Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024. This option is fully vested.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROCHE VINCENT

(Last) (First) (Middle)

ONE ANALOG WAY

(Street)

WILMINGTON MA 01887

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ANALOG DEVICES INC [ ADI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chair & CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Comm Stock - $.16-2/3 value	02/02/2026		M		10,000	A	$94.41	165,688.462	D
Comm Stock - $.16-2/3 value	02/02/2026		S		10,000(1)	D	$306.92	155,688.462	D
Comm Stock-$.16-2/3 value								23,515	I(2)	Vincent Roche 2024 Grantor Retained Annuity Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$94.41	02/02/2026		M			10,000	03/15/2021(3)	03/11/2030	Comm Stock - $.16-2/3 value	10,000	$94.41	44,637	D

Explanation of Responses:

1. These shares were sold pursuant to a 10b5-1 plan adopted by the Reporting Person on May 23, 2025.

2. Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024.

3. This option is fully vested.

Remarks:

	/s/ Shelly Shaw, General Counsel, by Power of Attorney	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ADI CEO Vincent Roche report on this Form 4?

Vincent Roche reported exercising 10,000 stock options and selling 10,000 Analog Devices (ADI) common shares. The option exercise price was $94.41 per share, and the sale price was $306.92 per share, all dated February 2, 2026.

How many Analog Devices (ADI) shares does Vincent Roche own after this transaction?

After the reported trades, Vincent Roche directly owns 155,688.462 Analog Devices (ADI) common shares. He also indirectly has 23,515 shares held in the Vincent Roche 2024 Grantor Retained Annuity Trust, in addition to 44,637 non-qualified stock options.

Was the ADI CEO’s 10,000-share sale part of a 10b5-1 trading plan?

Yes. The 10,000 Analog Devices (ADI) shares sold by Vincent Roche were disposed of under a 10b5-1 plan. The footnotes state this plan was adopted by the reporting person on May 23, 2025, before the February 2, 2026 sale.

What stock options did Vincent Roche exercise in this ADI Form 4 filing?

Vincent Roche exercised 10,000 non-qualified stock options with an exercise price of $94.41 per share. These options relate to common stock and were originally granted March 15, 2021, with an expiration date of March 11, 2030, and are fully vested.

How many stock options does the ADI CEO hold after the reported transactions?

Following the February 2, 2026 activity, Vincent Roche beneficially owns 44,637 non-qualified stock options in Analog Devices (ADI). These options are reported as directly held derivative securities, separate from his direct and indirect common stock holdings.

What indirect Analog Devices (ADI) holdings are associated with Vincent Roche?

The filing shows 23,515 ADI common shares held indirectly through the Vincent Roche 2024 Grantor Retained Annuity Trust. The footnote identifies this trust, dated October 3, 2024, as the holder of those shares, distinct from Roche’s directly owned holdings.